| Market Capitalization (Millions $) |
21 |
| Shares
Outstanding (Millions) |
9 |
| Employees |
16 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-38 |
| Cash Flow (TTM) (Millions $) |
-26 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Atossa Therapeutics Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington that is primarily focused on developing innovative therapies that can prevent and treat breast cancer, as well as other medical conditions that are related to breast health. The companyes mission is to improve the lives of patients by creating new treatments that are safe, effective, and patient-friendly.
Atossa Therapeutics has a number of proprietary products and technologies that it is developing for breast cancer and other indications. One of the companyes flagship products is Endoxifen, which is a potent selective estrogen receptor modulator (SERM) that can be used to reduce the risk of developing breast cancer. Endoxifen has shown promising results in early-stage clinical trials, and the company is currently conducting more comprehensive clinical trials to evaluate its safety and efficacy.
In addition to Endoxifen, Atossa Therapeutics has also developed a range of other products that are designed to treat breast cancer and improve breast health. These products include:
- Topical Endoxifen: This is a topical form of Endoxifen that can be applied directly to the breast tissue. It is being developed for use in women who have been diagnosed with precancerous breast lesions or who are at high risk of developing breast cancer.
- Oral Endoxifen: This is an oral form of Endoxifen that can be taken by women who have been diagnosed with breast cancer or who are at high risk of developing the disease. It is currently in clinical trials to evaluate its safety and efficacy.
- Immunotherapies: Atossa Therapeutics is also developing a range of immunotherapies that can be used to treat breast cancer. These therapies are designed to stimulate the bodyes immune system to target and eliminate cancer cells.
- Breast Health Products: The company has also developed a range of products that are designed to improve breast health and reduce the risk of breast cancer. These products include a breast pump and a diagnostic device that can be used to detect breast cancer at an early stage.
Overall, Atossa Therapeutics is a leader in the development of innovative therapies for breast cancer and other breast health-related conditions. The companyes proprietary products and technologies show great promise in the fight against breast cancer, and its ongoing clinical trials are expected to provide important insights into the safety and efficacy of these products.
Company Address: 1448 NW Market Street Seattle 98107 WA
Company Phone Number: 588-0256 Stock Exchange / Ticker: NASDAQ ATOS
|
3.85%